These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33047725)

  • 21. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum L-ficolin levels in patients with systemic lupus erythematosus.
    Watanabe H; Saito R; Asano T; Sato S; Iwadate H; Kobayashi H; Ohira H
    Mod Rheumatol; 2012 Nov; 22(6):899-902. PubMed ID: 22350641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
    Guo S; Ren J; Li Z; Fan X; Qin L; Li J
    Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
    Gottenberg JE; Dörner T; Bootsma H; Devauchelle-Pensec V; Bowman SJ; Mariette X; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Wegener WA; Goldenberg DM; Meno-Tetang G; Kosutic G; Gordon C
    Arthritis Rheumatol; 2018 May; 70(5):763-773. PubMed ID: 29381843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome.
    Nossent JC; Swaak AJ
    Lupus; 1998; 7(4):231-4. PubMed ID: 9643312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Assessment of Hand Joint Ultrasound Findings in Symptomatic Patients with Systemic Lupus Erythematosus and Sjögren's Syndrome: A Pilot Study.
    Lei L; Morgan S; Ntatsaki E; Ciurtin C
    Ultrasound Med Biol; 2019 Feb; 45(2):452-460. PubMed ID: 30401509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of circulating anti-N-methyl-
    Tay SH; Fairhurst AM; Mak A
    Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement.
    Kart Bayram GS; Erden A; Bayram D; Özdemir B; Karakaş Ö; Apaydın H; Ateş O; Güven SC; Armağan B; Gök K; Maraş Y; Omma A; Küçükşahin O; Topçuoğlu C; Erten Ş
    Lab Med; 2022 May; 53(3):285-289. PubMed ID: 34927690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
    Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
    Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stratification of Patients With Sjögren's Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic Implications.
    Martin-Gutierrez L; Peng J; Thompson NL; Robinson GA; Naja M; Peckham H; Wu W; J'bari H; Ahwireng N; Waddington KE; Bradford CM; Varnier G; Gandhi A; Radmore R; Gupta V; Isenberg DA; Jury EC; Ciurtin C
    Arthritis Rheumatol; 2021 Sep; 73(9):1626-1637. PubMed ID: 33645922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sjögren's syndrome associated with childhood-onset systemic lupus erythematosus].
    Iwata N; Mori M; Miyamae T; Ito S; Imagawa T; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Jun; 31(3):166-71. PubMed ID: 18587227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome.
    Lundtoft C; Sjöwall C; Rantapää-Dahlqvist S; Bengtsson AA; Jönsen A; Pucholt P; Wu YL; Lundström E; Eloranta ML; Gunnarsson I; Baecklund E; Jonsson R; Hammenfors D; Forsblad-d'Elia H; Eriksson P; Mandl T; Bucher S; Norheim KB; Auglaend Johnsen SJ; Omdal R; Kvarnström M; Wahren-Herlenius M; Truedsson L; Nilsson B; Kozyrev SV; Bianchi M; Lindblad-Toh K; ; Yu CY; Nordmark G; Sandling JK; Svenungsson E; Leonard D; Rönnblom L
    Arthritis Rheumatol; 2022 Nov; 74(11):1842-1850. PubMed ID: 35729719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of semaphorin 3A in patients with urothelial cancer.
    Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
    Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
    Cervera R; García-Carrasco M; Font J; Ramos M; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(4):361-5. PubMed ID: 9272295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity].
    Vadacca M; Margiotta D; Sambataro D; Buzzulini F; Lo Vullo M; Rigon A; Afeltra A
    Reumatismo; 2010; 62(4):259-65. PubMed ID: 21253619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus].
    Liu HJ; Shi LJ; Hu FL; Yao HH; Li ZG; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):829-834. PubMed ID: 29045964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases.
    Zhang W; Wang F; Wang H; Hua B; Feng X; Sun L
    Clin Rheumatol; 2018 Dec; 37(12):3337-3344. PubMed ID: 30276563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.